8:40 Fireside Chat: Reflecting on Lessons Learned from PhII/III Failures to Drive Urgency for Novel CNS Biomarker Research

• Evaluating past failures to identify key missteps, avoid repeating errors, and foster collective learning that propels the field forward with greater cohesion
• The blood-based biomarker revolution: Reviewing the latest progress to increase accessibility, sensitivity and scalability
• Evaluating the latest progress in neuroimaging technologies: Enhancing clinical value, navigating constraints, and integrating with fluid-based approaches 

Speakers:

Fernanda Stern

Senior Associate Director - Research Programs & Translational Research

Michael J. Fox Foundation